Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register.
Hero C, Karlsson SA, Franzén S, Svensson AM, Miftaraj M, Gudbjörnsdottir S, Andersson Sundell K, Eliasson B, Eeg-Olofsson K. Hero C, et al. BMJ Open Diabetes Res Care. 2020 Jan;8(1):e000719. doi: 10.1136/bmjdrc-2019-000719. BMJ Open Diabetes Res Care. 2020. PMID: 31958300 Free PMC article.
Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
Karlsson SA, Hero C, Svensson AM, Franzén S, Miftaraj M, Gudbjörnsdottir S, Eeg-Olofsson K, Eliasson B, Andersson Sundell K. Karlsson SA, et al. Among authors: hero c. BMJ Open. 2018 Mar 30;8(3):e020309. doi: 10.1136/bmjopen-2017-020309. BMJ Open. 2018. PMID: 29602853 Free PMC article.
Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.
Karlsson SA, Hero C, Eliasson B, Franzén S, Svensson AM, Miftaraj M, Gudbjörnsdottir S, Eeg-Olofsson K, Andersson Sundell K. Karlsson SA, et al. Among authors: hero c. Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1220-1232. doi: 10.1002/pds.4281. Epub 2017 Aug 11. Pharmacoepidemiol Drug Saf. 2017. PMID: 28799214 Free PMC article.